Reports on Corporate Concentration
Has CEO Bob Shapiro, the 'Goldfinger' of biotechnology, suddenly become the 'Man with the Minus Touch' ... or has Monsanto run afoul 007?
Alliances and Financial Stakes Grow in Human DNA Prospecting
Biotech Patents Distort and Discourage Innovation and Increase Costs for Dubious Drugs